Manuel, M., Tredan, O., Bachelot, T., Clapisson, G., Courtier, A., Parmentier, G., . . . Ménétrier-Caux, C. (2012). Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients. Landes Bioscience.
Citação norma ChicagoManuel, Manuarii, et al. Lymphopenia Combined With Low TCR Diversity (divpenia) Predicts Poor Overall Survival in Metastatic Breast Cancer Patients. Landes Bioscience, 2012.
MLA CitationManuel, Manuarii, et al. Lymphopenia Combined With Low TCR Diversity (divpenia) Predicts Poor Overall Survival in Metastatic Breast Cancer Patients. Landes Bioscience, 2012.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.